Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy

被引:11
作者
Corban-Wilhelm, H
Ehemann, V
Becker, G
Greulich, D
Braun, K
Debus, J
机构
[1] Deutsch Krebsforschungszentrum, Clin Cooperat Unit Radiotherapeut Oncol, D-69009 Heidelberg, Germany
[2] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
关键词
cytosine deaminase; thymidine kinase; cell death;
D O I
10.1038/sj.cgt.7700667
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Dunning R3327 AT-1 rat prostate tumor cells were transfected with a double-fusion suicide gene (CDglyTK) that coded for the cytosine deaminase from E. coli and the thymidine kinase (TK) from HSV-1. The resulting cell line AT-1/CDglyTK was incubated with 10 and 20 mug/ml 5-FC or 0.25 mug/ml GCV, or both 5-FC and GCV 96 hours before harvest. The MTS assay detected cell viabilities of 50+/-5 and 25+/-5% after 5-FC treatment, and 50+/-5% after GCV treatment. The dye exclusion and the colony-forming assay confirmed the data of the MTS assay with GCV (47+/-5 and 32+/-5%), but presented different results for the 5-FC incubation. We detected 100+/-1 and 85+/-5% viable cells after 10 mug/ml 5-FC, and 97+/-1 and 85+/-5% after 20 mug/ml 5-FC treatment, respectively. S-phase arrest in both suicide gene systems was noticeable and a significant increase in cell granularity was observed after incubation with GCV or GCV & 5-FC. This study demonstrates that 5-FC and the metabolized 5-FU act not only as genotoxic reagents, but also as RNA-directed agent, because of the recovery of the cells. On the other hand, a significant S-phase block could be observed after 24 hours incubation with GCV. This short time is enough to incorporate the genotoxic GCV metabolites in the nascent DNA to impair the cell cycle.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 29 条
[1]   Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies [J].
Aghi, M ;
Kramm, CM ;
Chou, TC ;
Breakefield, XO ;
Chiocca, EA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (05) :370-380
[2]   5-(3-CARBOXYMETHOXYPHENYL)-2-(4,5-DIMETHYLTHIAZOLYL)-3-(4-SULFOPHENYL)TETRAZOLIUM, INNER SALT (MTS) AND RELATED ANALOGS OF 3-(4,5-DIMETHYLTHIAZOLYL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE (MTT) REDUCING TO PURPLE WATER-SOLUBLE FORMAZANS AS CELL-VIABILITY INDICATORS [J].
BARLTROP, JA ;
OWEN, TC ;
CORY, AH ;
CORY, JG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (11) :611-&
[3]   Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases [J].
Beltinger, C ;
Fulda, S ;
Kammertoens, T ;
Meyer, E ;
Uckert, W ;
Debatin, KM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8699-8704
[4]  
Beltinger C, 2000, CANCER RES, V60, P3212
[5]  
Calabresi P., 1995, GOODMAN GILMANS PHAR, P1225
[6]   Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model:: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy [J].
Corban-Wilhelm, H ;
Hull, WE ;
Becker, G ;
Bauder-Wüst, U ;
Greulich, D ;
Debus, J .
GENE THERAPY, 2002, 9 (23) :1564-1575
[7]   USE OF AN AQUEOUS SOLUBLE TETRAZOLIUM FORMAZAN ASSAY FOR CELL-GROWTH ASSAYS IN CULTURE [J].
CORY, AH ;
OWEN, TC ;
BARLTROP, JA ;
CORY, JG .
CANCER COMMUNICATIONS, 1991, 3 (07) :207-212
[8]   METABOLISM OF PYRIMIDINE ANALOGS AND THEIR NUCLEOSIDES [J].
DAHER, GC ;
HARRIS, BE ;
DIASIO, RB .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (02) :189-222
[9]   ANALYSIS AND DISCRIMINATION OF NECROSIS AND APOPTOSIS (PROGRAMMED CELL-DEATH) BY MULTIPARAMETER FLOW-CYTOMETRY [J].
DIVE, C ;
GREGORY, CD ;
PHIPPS, DJ ;
EVANS, DL ;
MILNER, AE ;
WYLLIE, AH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1133 (03) :275-285
[10]   Herpes simplex virus type 1 infection imposes a G1/S block in asynchronously growing cells and prevents G1 entry in quiescent cells [J].
Ehmann, GL ;
McLean, TI ;
Bachenheimer, SL .
VIROLOGY, 2000, 267 (02) :335-349